Contactless magneto-permeabilization for intracellular plasmid DNA delivery in-vivo
Open Access
- 24 November 2012
- journal article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 8 (11) , 1707-1713
Abstract
Electroporation, an attractive process for delivering DNA and other molecules into target cells in vivo and in vitro is limited by the necessity of electrodes that need to be in contact with the subject or object to be electroporated. We have used magnetic fields, which do not require material contact with the subject, to temporarily permeabilize cells in guinea pig skin in vivo to enhance uptake and expression of GFP plasmid DNA. The results show for the first time that magnetic fields can trigger a process likely similar to electroporation. In designing the magnetic pulses, our most important criterion was a high rate of change of the magnetic field, based on the principle described by Michael Faraday which is expressed by the formula: E = -dB/dt, (E, electric field, B, magnetic field, t, time). Magnetic fields were generated by a flat electromagnet in a hand-held applicator positioned above the target tissue. The magnetic pulses had a peak magnetic flux density of 4 tesla; 50 pulses were applied in 5 sec. Biphasic magnetic pulses were twice as effective as monophasic pulses and about equally effective as traditional electroporation pulses . Advantages of magnetopermeabilization over electoporation include: No contact between applicator and subject (“contact-less”); no need for invasive, disposable, sterile electrodes (“needle-less”); no pain from needles and reduced overall pain; no known side effects; easier and faster to administer than electroporation; less expensive due to absence of disposables; and, importantly, greater tissue penetration of the magnetic field allowing treatment of anatomical areas inaccessible by electroporation.Keywords
This publication has 20 references indexed in Scilit:
- Technologies for enhanced efficacy of DNA vaccinesExpert Review of Vaccines, 2012
- Studies on magnetism and bioelectromagnetics for 45 years: From magnetic analog memory to human brain stimulation and imagingBioelectromagnetics, 2011
- Microsecond and nanosecond electric pulses in cancer treatmentsBioelectromagnetics, 2011
- Electro-gene transfer to skin using a noninvasive multielectrode arrayJournal of Controlled Release, 2011
- Enhancement of antigen specific humoral immune responses after delivery of a DNA plasmid based vaccine through a contact-independent helium plasmaVaccine, 2010
- Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic toolExpert Opinion on Drug Delivery, 2010
- Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptidesVaccine, 2010
- Tolerability of Two Sequential Electroporation Treatments Using MedPulser DNA Delivery System (DDS) in Healthy AdultsMolecular Therapy, 2009
- Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic MelanomaJournal of Clinical Oncology, 2008
- Plasmid-based gene therapy of diabetes mellitusGene Therapy, 2007